TGFB1 and breast carcinoma: We reported recently that acetylated microtubules are required for TGF-β-induced cancer-associated fibroblast activation in breast cancer tissues [38], suggesting that microtubule acetylation seems to be a prerequisite cellular factor for breast cancer progression and that the downregulation of microtubule acetylation is important in breast cancer therapy.